Health

Life Biosciences Reports Glaucoma Study Updates

Updated 2026-10-09 15:55 UTC 1 source Positive

Life Biosciences announced that three glaucoma patients have received a single injection of its experimental cellular reprogramming drug with no serious adverse events. The study updates were shared by STAT News.

Coverage timeline — 1 article

STAT News

STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug

Life Biosciences said yesterday that three glaucoma patients have now received a single injection of its experimental cellular reprogramming drug, with no serious adverse events.

2026-10-09 15:41 UTC